Neptune Technologies & Bioresources Inc Total Assets 2009-2019 | NEPT

Neptune Technologies & Bioresources Inc total assets from 2009 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Neptune Technologies & Bioresources Inc Annual Total Assets
(Millions of US $)
2019 $69
2018 $77
2016 $81
2015 $81
2015 $0
2014 $98
2014 $0
2013 $68
2013 $0
2012 $45
2012 $0
2011 $23
2011 $0
2010 $16
2010 $0
2009 $16
2009 $0
Neptune Technologies & Bioresources Inc Quarterly Total Assets
(Millions of US $)
Q4 2019 $69
Q3 2018 $70
Q2 2018 $75
Q1 2018 $74
Q3 2016 $83
Q2 2016 $75
Q1 2016 $76
Q4 2016 $76
Q4 2016 $0
Q3 2015 $66
Q2 2015 $70
Q1 2015 $75
Q4 2015 $88
Q3 2014 $99
Q2 2014 $109
Q1 2014 $116
Q4 2014 $98
Q3 2013 $61
Q2 2013 $65
Q1 2013 $64
Q4 2013 $68
Q4 2013 $0
Q3 2012 $76
Q2 2012 $49
Q1 2012 $49
Q4 2012 $45
Q3 2011 $39
Q2 2011 $36
Q1 2011 $35
Q4 2011 $23
Q3 2010 $23
Q2 2010 $19
Q1 2010 $19
Q4 2010 $16
Q3 2009 $16
Q2 2009 $15
Q1 2009 $15
Q4 2009 $16
Q3 2008 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.355B $0.018B
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.955B 29.11
Medtronic (MDT) Ireland $133.284B 19.04
Stryker (SYK) United States $75.636B 26.99
Boston Scientific (BSX) United States $57.976B 27.79
Baxter (BAX) United States $42.043B 26.50
Zimmer Biomet Holdings (ZBH) United States $24.226B 15.56
Smith & Nephew SNATS (SNN) United Kingdom $19.156B 0.00
ResMed (RMD) United States $17.217B 32.90
Canopy Growth (CGC) Canada $13.835B 0.00
Bio-Rad Laboratories (BIO) United States $9.076B 48.12
Aurora Cannabis (ACB) Canada $7.403B 73.00
Insulet (PODD) United States $7.147B 520.74
Hill-Rom Holdings (HRC) United States $6.992B 21.20
Perrigo (PRGO) Ireland $6.052B 10.23
Haemonetics (HAE) United States $6.021B 49.14
GW Pharmaceuticals (GWPH) United Kingdom $5.237B 0.00
ICU Medical (ICUI) United States $5.130B 30.61
Hutchison China MediTech (HCM) China $3.814B 0.00
Neogen (NEOG) United States $3.238B 52.65
Agios Pharmaceuticals (AGIO) United States $2.981B 0.00
NuVasive (NUVA) United States $2.962B 24.19
National Vision Holdings (EYE) United States $2.499B 53.25
Quidel (QDEL) United States $2.360B 24.49
Aphria (APHA) $1.687B 0.00
Cardiovascular Systems (CSII) United States $1.495B 858.80
Phibro Animal Health (PAHC) United States $1.220B 18.28
AtriCure (ATRC) United States $1.159B 0.00
VAREX IMAGING (VREX) United States $1.119B 23.75
Lantheus Holdings (LNTH) United States $1.081B 28.71
OrganiGram Holdings (OGI) Canada $0.993B 0.00
NanoString Technologies (NSTG) United States $0.935B 0.00
PetIQ (PETQ) United States $0.899B 21.84
Quanterix (QTRX) United States $0.846B 0.00
MacroGenics (MGNX) United States $0.812B 0.00
Omeros (OMER) United States $0.794B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.771B 21.61
Cerus (CERS) United States $0.682B 0.00
TG Therapeutics (TGTX) United States $0.638B 0.00
Surmodics (SRDX) United States $0.572B 83.20
OraSure Technologies (OSUR) United States $0.552B 25.40
LeMaitre Vascular (LMAT) United States $0.545B 26.37
Meridian Bioscience (VIVO) United States $0.489B 14.95
Evolus (EOLS) United States $0.371B 0.00
Vapotherm (VAPO) United States $0.364B 0.00
Zynex (ZYXI) United States $0.355B 36.73
BioLife Solutions (BLFS) United States $0.311B 97.41
Utah Medical Products (UTMD) United States $0.302B 20.93
Bovie Medical (APYX) United States $0.217B 0.00
Cytosorbents (CTSO) United States $0.210B 0.00
Owens & Minor (OMI) United States $0.193B 4.08
Chimerix (CMRX) United States $0.173B 0.00
Rockwell Medical (RMTI) United States $0.172B 0.00
Fonar (FONR) United States $0.140B 7.38
Female Health (VERU) United States $0.134B 0.00
BRAINSWAY LTD (BWAY) Israel $0.111B 0.00
Neurotrope (NTRP) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Surface Oncology (SURF) United States $0.088B 0.00
United-Guardian (UG) United States $0.087B 19.21
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Senestech (SNES) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.039B 13.58
Conatus Pharmaceuticals (CNAT) United States $0.031B 0.00
GUARDION HEALTH (GHSI) United States $0.030B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.73